00 : 00 / 05: 00 (Preview)
Portal vein thrombosis (PVT) is a frequent complication in cirrhosis and its prevalence increases with disease severity. The difficulty in managing PVT is in determining if the risk of bleeding is greater than the risk of life-threatening thrombus extension. There are several therapy options are presently available; join us as we us examine the risks and benefits that we should carefully consider while managing our patients.
Medflix is a new platform by PlexusMD, India's most active and trusted doctor community. On Medflix, you can discover live surgeries, discussions, conferences and courses from some of the top doctors and institutions across the world. Join clubs in your areas of interest and access hundreds of amazing live discussions everyday.
* This is a Takeda sponsored webinar.
This information is solely intended for the use of Registered Medical Practitioner and Hospital only. This information should not be used or shared or distributed to any other person/party and should be strictly by the intended parties for the intended purposes only. For more information, please refer to full Prescribing Information.
This material contains copyright protected information, content; the use of which is limited by law and this material cannot be reproduced, replicated, used or modified by any person for their own use or further distribution.
TAKEDA and the “TAKEDA logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited.” For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory.
Copyright © 2020 Takeda Pharmaceutical Company Limited. All rights reserved.
Contact us: Baxalta Bioscience India Pvt. Ltd. (part of Shire)
Shire is part of Takeda Pharmaceutical Company Ltd.
6th Floor, Tower-C, Building No.8, DLF Cyber City, DLF Phase-II,
Gurgaon-122002, Haryana, India